Georges Gaudriault
Chief Tech/Sci/R&D Officer at DEINOVE
Profile
Georges Gaudriault is currently the Chief Scientific Officer at Deinove SA. Previously, he held positions as the Scientific Director at Obe Therapy Biotechnology SAS, Obetherapy, and MedinCell SA. Dr. Gaudriault obtained his undergraduate, graduate, and doctorate degrees from the University of Nice Sophia Antipolis.
Georges Gaudriault active positions
Companies | Position | Start |
---|---|---|
DEINOVE | Chief Tech/Sci/R&D Officer | 2017-05-22 |
Former positions of Georges Gaudriault
Companies | Position | End |
---|---|---|
Obe Therapy Biotechnology SAS
Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | - |
Obetherapy
Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Chief Tech/Sci/R&D Officer | - |
MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | - |
Training of Georges Gaudriault
University of Nice Sophia Antipolis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MEDINCELL S.A. | Health Technology |
Private companies | 3 |
---|---|
Deinove SA
Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Obe Therapy Biotechnology SAS
Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Health Services |
Obetherapy
Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Health Technology |
- Stock Market
- Insiders
- Georges Gaudriault